A Merrimack director purchased 69K shares at $3.65 per share, while a Catalent director sold 5.39M shares at $99.26 per share Welcome to "Fly Insider," The Fly's weekly recap of notable insider stock transactions.
NOTABLE INSIDER PURCHASES: Significant insider purchases reported in the prior week from November 23 through November 27 include:
- Beneficial owner of BioLife Solutions (BLFS) Casdin Partners purchased 1,600,000 shares of company stock at $22.50 per share for a total transaction value of $36,000,000
- Director of Net 1 UEPS Technologies (UEPS) Anthony Ball purchased 88,911 shares of company stock at $3.39 per share for a total transaction value of $301,408
- Director of Merrimack Pharmaceuticals (MACK) Eric Andersen purchased 69,088 shares of company stock at $3.65 per share for a total transaction value of $252,171
- Beneficial owner of FTS International (FTSI) THRC Holdings purchased 876,280 shares of company stock at $15.33 per share for a total transaction value of $13,435,475
- Director of Coty (COTY) Johannes Huth purchased 1,000,000 shares of company stock at $6.20 per share for a total transaction value of $6,199,000
NOTABLE INSIDER SALES: Significant insider sales in the prior week from November 23 through November 27 include:
- Director of Catalent (CTLT) Peter Zippelius sold 5,392,280 shares of company stock at $99.26 per share for a total transaction value of $535,237,713
- Beneficial owner of Container Store Group (TCS) Green Equity sold 5,500,000 shares of company stock at $10.00 per share for a total transaction value of $55,000,000
- Chairman of Carlyle Group (CG) David Rubinstein sold 2,000,000 shares of company stock at $27.30 per share for a total transaction value of $54,600,000
- Beneficial owner of Duck Creek Technologies (DCT) Accenture sold 480,000 shares of company stock at $39.77 per share for a total transaction value of $19,089,600
- COO of Palantir Technologies (PLTR) Shyam Sankar sold 600,000 shares of company stock at $20.42 per share for a total transaction value of $12,250,620.
NOTABLE PRICE MOVEMENT AFTER INSIDER TRANSACTION: Shares of Merrimack Pharmaceuticals are up 13% since Eric Andersen purchased 69,088 shares, while shares of Catalent are down over 6% since director Peter Zippelius sold 5.39M shares.
Symbols:
BLFS UEPS MACK FTSI COTY CTLT TCS CG PLTR Keywords: insider trading, insider buying, insider selling, executive trading, executive buying, executive selling, stock transactions, SEC